October 21, 2026Stocks·Neutral·corporate action
Valion Bio reviews strategic options for contract manufacturing unit Velocity Bioworks, including possible sale
Valion Bio announced a review of strategic options for its contract manufacturing unit Velocity Bioworks, including a possible sale of the business.
Detected & updated continuously · Source: Nebula
Story subjects